Trasylol Lawsuit

If you or someone you love were injured by Trasylol, please contact our Trasylol lawyers for a free consultation. Call 1-877-318-0580 or contact us online. You may be entitled to compensation.* We can evaluate your case, answer your questions, and help you understand your legal rights, including the filing of a Trasylol lawsuit.

The Trasylol lawyers at the Simmons firm are investigating occurrences where heart surgery patients died after being treated with Trasylol, a protein that is used as medication administered by injection to reduce bleeding during complex surgery. Trasylol is manufactured by Bayer AG and has been used in nearly a third of all open heart surgeries in the US since 1993.

WHAT IS TRASYLOL?

Trasylol is a protease inhibitor. It works to reduce inflammation during bypass surgery, reducing blood loss and the need for blood transfusions.¹

TRASYLOL SIDE EFFECTS

Common side effects include:

Constipation; diarrhea; difficulty urinating; infection (eg, fever, chills, sore throat); lightheadedness; sleeplessness; vomiting.

Severe side effects include:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); asthma; chest pain; confusion; decreased urination; fast or irregular heartbeat; lung disorder; nausea; numbness of an arm or leg; one-sided weakness; severe stomach pain; sudden severe headache, dizziness, fainting, or vomiting; sudden weight gain; swelling of the hands, legs, or feet; vision or speech changes.²

See important information on surgery risks that may have initiated the need for possible Trasylol lawsuits.

FDA WARNING

November 5, 2007, Bayer suspended the marketing of Trasylol until final results of the BART study became available.  The BART study showed an increase in the risk of death with Trasylol compared with aminocaproic acid and tranexamic acid.  According to Dr. John K. Jenkins, director of the FDA's Office of New Drugs, the FDA cannot identify a patient population in which the use of Trasylol (aprotinin) outweighs the risk.³

On May 15, 2008, Bayer Pharmaceuticals, the manufacturer of Trasylol (aprotinin), notified the FDA of their intent to remove all remaining supplies of Trasylol from hospital pharmacies and warehouses.⁴

CONTACT THE SIMMONS FIRM

At the Simmons firm, we handle a wide range of legal matters. Contact the Simmons firm if you have questions about mesothelioma, commercial, intellectual property, defective medical devices and pharmaceutical litigation. Legal consultations are free, and you are under no obligation.  

^{* Please note that recovery results vary per client. The recovery amounts in each case reflect the specific facts of that case. Further, recovery amounts in past cases are not a guarantee of future results.}